Diagnosis of gastric adenocarcinoma using a scoring system: combined assay of serological markers of Helicobacter pylori infection, pepsinogen I and gastrin
- PMID: 7773344
- DOI: 10.1007/BF02348659
Diagnosis of gastric adenocarcinoma using a scoring system: combined assay of serological markers of Helicobacter pylori infection, pepsinogen I and gastrin
Abstract
This study was carried out to develop a scoring system for the diagnosis of gastric adenocarcinoma (GAC). A total of 686 subjects, 150 patients with GAC, 182 with gastric ulcer, 127 with duodenal ulcer, and 227 subjects with negative findings, were enrolled. Analysis of the likelihood ratio (LR) showed that patients with advanced age, ulcer in the stomach, low serum levels of pepsinogen I (PGI), low PGI x gastrin values, and low PGI/gastrin ratio were likely to have GAC. Of these indicators, the serum PGI level had the greatest weight, with a LR of 7.59 for the group with a level < 30 ng/ml. A scoring system combining serum PGI level, Helicobacter pylori seropositivity, and gastric ulcer status was derived, using a logistic regression model. This scoring system was found to be better than any one-parameter criterion for diagnosing GAC after evaluation by the area under the receiver operating characteristic curve (0.84; 95% confidence interval, 0.81-0.88) or by specificity-fixed sensitivity (sensitivity 0.82 at specificity 0.72, sensitivity 0.87 at specificity 0.66, sensitivity 0.96 at specificity 0.44). This scoring system may be potentially useful as a new model for the noninvasive diagnosis of GAC in the future.
Similar articles
-
Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group.Gut. 1998 Jul;43 Suppl 1(Suppl 1):S39-46. doi: 10.1136/gut.43.2008.s39. Gut. 1998. PMID: 9764039 Free PMC article. Review.
-
A novel tree-structured analysis for non-invasive diagnosis of gastric adenocarcinoma.Anticancer Res. 1995 Nov-Dec;15(6B):2739-43. Anticancer Res. 1995. PMID: 8669856
-
Serum levels of pepsinogen I and gastrin in gastric carcinoma: the influence of Helicobacter pylori infection and tumor characteristics.Hepatogastroenterology. 1993 Dec;40(6):600-3. Hepatogastroenterology. 1993. PMID: 8119648
-
Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.J Dig Dis. 2007 Feb;8(1):15-22. doi: 10.1111/j.1443-9573.2007.00271.x. J Dig Dis. 2007. PMID: 17261130
-
[Roles of pepsinogen test, ABC method and barium X-ray examination on gastric cancer screening].Nihon Shokakibyo Gakkai Zasshi. 2013 Feb;110(2):225-33. Nihon Shokakibyo Gakkai Zasshi. 2013. PMID: 23381210 Review. Japanese. No abstract available.
Cited by
-
Importance of gastrin in the pathogenesis and treatment of gastric tumors.World J Gastroenterol. 2009 Jan 7;15(1):1-16. doi: 10.3748/wjg.15.1. World J Gastroenterol. 2009. PMID: 19115463 Free PMC article. Review.
-
Blood tests in the management of Helicobacter pylori infection. Italian Helicobacter pylori Study Group.Gut. 1998 Jul;43 Suppl 1(Suppl 1):S39-46. doi: 10.1136/gut.43.2008.s39. Gut. 1998. PMID: 9764039 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical